Spark Therapeutics, Inc.

Biotechnology company · Philadelphia, Pennsylvania, United States

Spark Therapeutics, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2013. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has reported private securities offerings to the US SEC, most recently $73 million sold in a notice filed in 2014.

Profile compiled from public records. Is this your company? Request a correction or update

Spark Therapeutics at a glance

Typebiotechnology company
HeadquartersPhiladelphia, Pennsylvania, United States
Earliest incorporation on record2013
SEC industryBiological Products, (No Diagnostic Substances)
FDA-registered sites1
SEC CIK1609351

What does Spark Therapeutics do?

Operations at its FDA-registered drug sites

AnalysisAPI manufacturing

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $72.8 million sold (2014).

Where is Spark Therapeutics located?

Headquarters: Philadelphia, Pennsylvania, United States

  • Philadelphia, PennsylvaniaSpark Therapeutics, Inc. · FDA drug site

Frequently asked questions about Spark Therapeutics

Where is Spark Therapeutics headquartered?

Spark Therapeutics, Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does Spark Therapeutics do?

Spark Therapeutics, Inc. is a biotechnology company. Its FDA-registered drug sites are registered for analysis and API manufacturing. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Spark Therapeutics founded?

The earliest incorporation on record for Spark Therapeutics, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.